cogrx.com (CGTX) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Cognition Therapeutics (CGTX) grafigidagi chiziqli narx harakati neyronlar yemirilishiga qarshi dori vositalari ishlab chiquvchisining faoliyatini aks ettiradi, uning kelajakdagi foydasi kapital xarajatlarsiz patent modeliga bog'liq. Ushbu ko'rsatkichning joriy qiymati 0.01 ni tashkil etadi. Kompaniyaning o'sishi demensiyaga qarshi dori vositalari sinovlari natijalari va tashqi grantlarga bog'liq. Tijoratlashtirilgan mahsulotlarning yo'qligi salbiy pul oqimini keltirib chiqaradi, bu esa biznesni yangi investitsiyalarga qaram qiladi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261031&filename=GURU_Markets_-_CGTX_-_Cognition-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "CGTX - Cognition Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Cognition Therapeutics, Inc. (CGTX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Cognition Therapeutics|CGTX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Cognition Therapeutics Inc.|CGTX - Kompaniya qarzlari|Balans qiymatiga qarzlar Cognition Therapeutics, Inc.|CGTX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Cognition Therapeutics|Shoshilinch likvidlik koeffitsiyenti cogrx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:CGTX (cogrx.com)
Ushbu ko'rsatkich kompaniyaning o'z kapitaliga nisbatan uzoq muddatli qarz moliyalashtirishga bog'liqligini o'lchab, moliyaviy avtonomiya darajasini va kredit bosimi xavfini aniqlaydi. Uzoq muddatli majburiyatlarning kapitalga nisbatini tahlil qilish orqali investor Cognition Therapeutics (CGTX) kompaniyasining noelastik talab sharoitida noyob miya sinapslarini himoya qiluvchi dori vositalarini ishlab chiqishni qo'llab-quvvatlash qobiliyatini baholashi mumkin, bu esa biznesning uzoq muddatli barqarorligiga bevosita ta'sir qiladi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Praxis Corp|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL (ceribell.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PRTA: Uzoq muddatli qarzning kapitalga nisbati|ALEC - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER (Omeros Corp.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzdorlikning kapitalga nisbati acimmune.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN (Tevogen Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|inhibikase.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SAVA|ASRT (Assertio Therapeutics) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati COYA|VTGN (vistagen.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|acumenpharm.com (ABOS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATHE (Alterity Therapeutics)|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|relmada.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|GRCE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANEW Medical KLTO|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|revivapharma.com - Uzoq muddatli kreditlarning kapitalga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati